The use of intraperitoneal instillation of lidocaine improves early postoperative pain management after cesarean delivery. Furthermore, it reduces the number of women requesting systemic opioids in the immediate postpartum period. Women undergoing peritoneal closure may particularly benefit from this intervention.

The optimal time interval between PIEB of 10 mL of bupivacaine 0.0625% with fentanyl 2 μg/mL is approximately 40 minutes. Further studies to determine the efficacy of this regimen throughout the entire duration of labor are warranted.

Our study shows that an increase in the oxytocin recovery interval is associated with a decrease in blood loss at CD in women with oxytocin augmented labour. These data support discontinuing the oxytocin infusion as soon as the decision is made to proceed with CD for labour arrest, particularly in morbidly obese women.

(Anesth Analg. 2017;124(2):554–559) Poorly controlled postpartum pain can place a patient at risk for chronic pain, postpartum depression, and negatively impact maternal-fetal interactions. Although multimodal analgesia has greatly improved pain control in general for these women, there remain a proportion of patients who report inadequate postoperative pain relief. Intraperitoneal local anesthetics, which have proven successful in abdominal surgery pain control, may be an effective adjunct. The authors of this study evaluated the effect of intraperitoneal lidocaine on postcesarean delivery pain as part of a multimodal analgesia regimen.